CORGIS, based at the Department of Dermatology and Allergy, aims to investigate the pathogenesis, risk factors, comorbidities, epidemiology and the treatment and care of inflammatory skin diseases. The Department has the resources and experience needed for clinical drug testing and CORGIS seeks to further investigate and develop new therapeutic treatments for these often under-studied skin diseases.
The main research areas are currently:
- Psoriasis, optimal treatment and control
- Psoriasis, comorbidity and the importance of treatment
- Psoriasis, new treatments
- Atopic dermatitis, the skin barrier and the importance of the immune system
- Atopic dermatitis, risk factors
- Atopic dermatitis, comorbidity and the importance of treatment
- Atopic dermatitis, new treatments
- Skin barrier function and significance of disease
- Rosacea, comorbidity
- Lupus, risk factors
Professor DmSci, PhD. Lone Skov
Write to Professor DmSci, PhD. Lone Skov
Head of department, Associate Professor, DmSci. Claus Zachariae,
Write to Head of deparment, Associate Professor, DmSci. Claus Zachariae
The research unit is also affiliated a large staff of senior researchers, PhD students, medical students, medical laboratory technicians and research nurses.
Alexander Egeberg, Ph.D., MD
CORGIS routinely collaborates with a large number of international and national partners, including Herlev and Gentofte Hospital Department of Cardiology, Department of Internal Medicine, and the Steno Diabetes Center.
CORGIS publishes more than 70 scientific articles annually in international peer-reviewed journal.
The research is funded partly by private and public foundations and partly through collaboration with industry.